Samrat Pharmachem Limited (BOM:530125)
324.95
+6.95 (2.19%)
At close: Aug 29, 2025
Samrat Pharmachem Revenue
Samrat Pharmachem had revenue of 756.52M INR in the quarter ending June 30, 2025, a decrease of -6.40%. This brings the company's revenue in the last twelve months to 2.81B, down -7.95% year-over-year. In the fiscal year ending March 31, 2025, Samrat Pharmachem had annual revenue of 2.86B with 1.50% growth.
Revenue (ttm)
2.81B
Revenue Growth
-7.95%
P/S Ratio
0.36
Revenue / Employee
87.72M
Employees
32
Market Cap
1.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 2.86B | 42.22M | 1.50% |
Mar 31, 2024 | 2.82B | -291.06M | -9.37% |
Mar 31, 2023 | 3.11B | 888.86M | 40.06% |
Mar 31, 2022 | 2.22B | 426.92M | 23.83% |
Mar 31, 2021 | 1.79B | 416.39M | 30.28% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Hindustan Unilever | 639.28B |
Infosys | 1,672.76B |